{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:11:00Z","timestamp":1761707460815},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1053\/sonc.2002.32751","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"23-26","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S6","title":["Improving outcomes in transplantation"],"prefix":"10.1053","volume":"29","author":[{"given":"Wolfram","family":"Brugger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/sonc.2002.32751_BIB1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.32751_BIB2","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.1998.16.5.1922","article-title":"Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: Results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group","volume":"16","author":"Hiddemann","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.32751_BIB3","first-page":"3","article-title":"Evaluation and management of mantle cell lymphoma","volume":"6","author":"Press","year":"1996","journal-title":"Adv Leuk Lymph"},{"key":"10.1053\/sonc.2002.32751_BIB4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.6610211","article-title":"Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11; 14) chromosome translocation","volume":"224","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"key":"10.1053\/sonc.2002.32751_BIB5","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1053\/sonc.2002.32751_BIB6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1994.12.6.1177","article-title":"Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma","volume":"12","author":"Rohatiner","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.32751_BIB7","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.32751_BIB8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00062752-199603040-00004","article-title":"Non-Hodgkin's lymphoma","volume":"3","author":"Bierman","year":"1996","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/sonc.2002.32751_BIB9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.leu.2401488","article-title":"Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: Evidence for long-term clinical and molecular remissions","volume":"13","author":"Tarella","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/sonc.2002.32751_BIB10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/stem.150297","article-title":"Purging peripheral blood progenitor cell grafts from lymphoma cells: Quantitative comparison of immunomagnetic CD34+ selection systems","volume":"15","author":"Paulus","year":"1997","journal-title":"Stem Cells"},{"key":"10.1053\/sonc.2002.32751_BIB11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V63.6.1424.1424","article-title":"Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation","volume":"63","author":"Anderson","year":"1984","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.32751_BIB12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.32751_BIB13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s002620050016","article-title":"Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells","volume":"48","author":"Shan","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/sonc.2002.32751_BIB14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1172\/JCI110005","article-title":"A unique surface antigen identifying lymphoid malignancies of B cell origin","volume":"67","author":"Nadler","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1053\/sonc.2002.32751_BIB15","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.32751_BIB16","first-page":"1927","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study","volume":"92","author":"Coiffier","year":"1998","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/sonc.2002.32751_BIB17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/11.suppl_1.S117","article-title":"Treatment of mantle-cell lymphoma with rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response","volume":"11","author":"Foran","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.32751_BIB18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","article-title":"Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy","volume":"17","author":"Czuczman","year":"1999","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1053\/sonc.2002.32751_BIB19","first-page":"141a","article-title":"In vivo purging with rituximab before autologous peripheral blood progenitor cell (PBPC) transplantation in lymphoma patients (pts)","volume":"94","author":"Salles","year":"1999","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/sonc.2002.32751_BIB20","first-page":"184a","article-title":"Efficiency of in vivo purging with rituximab followed by high-dose therapy (HDT) with autologous peripheral blood stem cell transplantation (PBSCT) in B-cell non-Hodgkin's lymphomas (NHL). A single institution study","volume":"96","author":"Haioun","year":"2000","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/sonc.2002.32751_BIB21","first-page":"384a","article-title":"Adjuvant rituximab after autologous peripheral blood stem cell transplant (APBSCT) results in delayed immune reconstitution without increase in infectious complications","volume":"96","author":"Horwitz","year":"2000","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/sonc.2002.32751_BIB22","first-page":"791a","article-title":"High frequency of molecular remissions associated with Rituxan or IFN immunotherapy following ASCT for follicular NHL","volume":"96","author":"Buckstein","year":"2000","journal-title":"Blood"},{"issue":"suppl 1)","key":"10.1053\/sonc.2002.32751_BIB23","first-page":"482a","article-title":"Treatment of follicular and mantle cell non-Hodgkin's lymphoma with anti-CD20 antibody rituximab after high-dose chemotherapy with autologous CD34+ enriched peripheral blood stem cell transplantation","volume":"96","author":"Brugger","year":"2000","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.32751_BIB24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/sj.leu.2401889","article-title":"Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3' BCL2 breakpoints and evidence of a new cluster","volume":"14","author":"Buchonnet","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/sonc.2002.32751_BIB25","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1182\/blood.V93.9.3081","article-title":"Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma","volume":"93","author":"Lopez-Guillermo","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.32751_BIB26","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood.V81.12.3449.3449","article-title":"Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma","volume":"81","author":"Gribben","year":"1993","journal-title":"Blood"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377540250172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377540250172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T21:16:24Z","timestamp":1581023784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009377540250172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S009377540250172X"],"URL":"https:\/\/doi.org\/10.1053\/sonc.2002.32751","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}